Company intelligence / Profile preview
Anagram Therapeutics
Framingham, Massachusetts, United Statesanagramtx.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
ANG003, the lead product, demonstrated positive results in a dose-ranging Phase 1 study in people with cystic fibrosis-related exocrine pancreatic insufficiency. The therapy was well tolerated and showed a statistically significant dose-dependent increase in fat absorption markers such as DHA and EPA. The company’s pipeline leverages proprietary oral enzyme technologies to address rare diseases involving malabsorption and nutrient metabolism disorders.[7]
- Therapeutic areas
- GastroenterologyMetabolic DisordersInfectious Diseases
- Modalities
- Orally delivered enzyme therapeuticsenzyme replacement therapies (ERT)non-porcine enzymes[1][2][7]
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →03
Partnerships
Cystic Fibrosis Foundation is an investor/partner[4]
Beyond the preview
Go deeper on Anagram Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Anagram Therapeutics.